Nintedanib Ethanesulfonate (CAS 656247-18-6)
« Back to Anti-Cancer API
Nintedanib Ethanesulfonate
CAS No. 656247-18-6
乙磺酸尼达尼布
Chemical structure
| CAS No. | 656247-18-6 |
|---|---|
| Synonyms | (3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester ethanesulfonate |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C33H39N5O7S |
| Molecular Weight | 649.8 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Yellow to off-white solid powder |
Application and positioning
Nintedanib ethanesulfonate is a triple-kinase inhibitor of VEGFR, FGFR and PDGFR, supplied as the ethanesulfonate salt. It is used in oral capsules for advanced lung adenocarcinoma and for idiopathic pulmonary fibrosis. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Niraparib Tosylate Monohydrate (CAS 1613220-15-7)
- Olaparib (CAS 763113-22-0)
- Osimertinib Mesylate (CAS 1421373-66-1)
- Pazopanib Hydrochloride (CAS 635702-64-6)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 656247-18-6 · PubChem CID 135476717